Blood Research Hematology

Frontline daratumumab, lenalidomide, and dexamethasone in patients older than 80 years with newly diagnosed multiple myeloma: treatment durability, infectious complications, and nutritional vulnerability

Yuichi Horigome, Koichi Ehata, Noriyuki Tadera, Kei Hayama, Hirotoshi Kamata, Takahiro Suzuki, Koji Miyazaki
Springer Nature · 2026-08-26 · DOI 10.1007/s44313-026-00165-y

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →